Pharmacokinetics of Dexamethasone when Administered with Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting and Differences in Dose-Dependent Antiemetic Effects.

Asian Pacific journal of cancer prevention : APJCP(2021)

Cited 0|Views5
No score
Abstract
Administration of a higher dexamethasone dose on day 3 improved the antiemetic effect of the combined regimen in patients with cancer who underwent HEC.
.
More
Translated text
Key words
CYP3A4,Highly emetogenic chemotherapy,dexamethasone,fosaprepitant,pharmacokinetics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined